Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
about
Biomarkers and severe asthma: a critical appraisalBiomolecular markers in assessment and treatment of asthmaPathogenesis of small airways in asthmaExhaled Breath Condensate: Technical and Diagnostic AspectsCurrent and future biomarkers in allergic asthma.Intranasal Administration of Recombinant Mycobacterium smegmatis Inducing IL-17A Autoantibody Attenuates Airway Inflammation in a Murine Model of Allergic AsthmaBiomarkers of therapy responsiveness in asthma: pitfalls and promises.Recent advances in asthma biomarker research.CCL11 as a potential diagnostic marker for asthma?Clinical Significance of the Dynamic Changes in Serum Eotaxin, Interleukin 13 and Total IgE in Children with Bronchial Asthma.The Flavonoid 7,4'-Dihydroxyflavone Prevents Dexamethasone Paradoxical Adverse Effect on Eotaxin Production by Human Fibroblasts.Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease.Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children.Wentong decoction cures allergic bronchial asthma by regulating the apoptosis imbalance of EOS.Anti-inflammatory effects of moxifloxacin on rat airway smooth muscle cells exposed to allergen: Inhibition of extracellular-signal-regulated kinase and nuclear factor-κB activation and of interleukin-8 and eotaxin synthesis.Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis
P2860
Q26782718-C4064BCA-B50C-4EA7-810F-95E9C4FC2FA8Q26994979-24FA26CE-CDBB-41AA-A6A6-E6618B0FEC62Q27026802-3255F32D-694D-4E1D-B0CD-DE6F6E39B95EQ28082250-FB46C16F-C398-42A7-B8E2-8AAE1F2C1559Q35878914-F72FC66C-8B04-4117-A10D-6007F25AE459Q35956060-8914753B-615C-4886-B514-2320A0AAF549Q37864705-E2F800EA-2BD3-46B7-AD84-DEA7B4CF5385Q38125948-C2FC8ADF-1E74-4A70-BB7D-79FAE1B625CFQ38209386-67FC2B4D-2E05-4C1C-AA42-FB0C9D6D73F7Q39119363-D915A923-E0F9-45E8-8474-B27926E7B62DQ47994498-009B21FC-3B6A-45D4-A6B4-44ECED9568F3Q49201946-D0502FE2-94D5-4C1F-A3E4-436E1A61E550Q50928137-41CA799F-9B64-49AC-A91B-EC4E000DC30CQ53689680-FF164D01-ED51-431A-8E79-7961EB75A272Q54509455-F89C9375-865D-478F-B428-CE76AFA5346AQ58885868-7669E775-8871-4B5C-BB41-7DC866C23371
P2860
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@ast
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@en
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@nl
type
label
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@ast
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@en
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@nl
prefLabel
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@ast
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@en
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@nl
P2093
P2860
P356
P1433
P1476
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients
@en
P2093
Anna Bodzenta-Lukaszyk
Elzbieta Zietkowska
Maria M Tomasiak-Lozowska
Roman Skiepko
Ziemowit Zietkowski
P2860
P2888
P356
10.1186/1465-9921-11-110
P577
2010-08-12T00:00:00Z
P5875
P6179
1031553072